Model number
|
Linear term for absolute risk (α) model (/1000 Scored cells /Gy)
|
Linear term for relative risk (α) (/Gy)
|
Exponential term (β) (/Gy)
|
Deviance (df)
|
p-value
|
---|
|
AIC-minimizing background model (no dose term)
|
1
|
-
|
-
|
-
|
106.04 (75)
| |
|
Absolute risk model in dose (1), background adjusted using AIC-minimizing model
|
2
|
3.03 (−0.78a, 7.65)
|
-
| |
102.56 (74)
|
0.1170b
|
3
|
0.71 (−3.05a, 16.40)
|
-
|
2.51 (−5.36, 11.05a)
|
102.10 (73)
|
0.5710c
|
|
Relative risk model in dose (2), background adjusted using AIC-minimizing model
|
4
|
-
|
1.19 (−0.49, 3.93)
|
-
|
103.60 (74)
|
0.1902b
|
5
|
-
|
0.14 (−0.97a, 7.98)
|
4.27 (−8.36a, 16.89a)
|
102.67 (73)
|
0.4205d
|
- All p-values relate improvement in fit evaluated via an F-test. All models adjust for background variables that minimize Akaike Information Criterion (AIC), as in Appendix 1 Table 7. 2-sided p-values and confidence intervals are adjusted for overdispersion
-
aWald-based CI
-
b
p-value of improvement in fit over null model in dose (model number 1)
-
c
p-value of improvement in fit over linear model in dose (model number 2)
-
d
p-value of improvement in fit over linear model in dose (model number 4)